Propofol and nociception

Earl Carstens, Joseph F. Antognini, Kenichi Takechi

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Propofol (2,6-diisopropylphenol) is an injectable agent that is commonly used for general anesthesia. In addition to its central nervous system depressant action, propofol may exhibit temporary analgesia although this has been debated. Several studies have reported analgesic effects of subhypnotic doses of propofol on pain perception in humans. Moreover, some recent clinical studies have reported that surgery patients receiving propofol anesthesia experienced reduced postoperative pain. These findings are in marked contrast to the well-known algesic effects of propofol, which induces pain upon intravenous injection or intradermal injection in humans and elicits nocifensive behavior in mice. Recent experiments also demonstrate that propofol directly activates the thermosensitive transient receptor potential (TRP) channels TRPV1 and TRPA1 , which are well-known receptors involved in nociception. Based on 3-compartment models of drug pharmacokinetics, it would be expected that propofol, which is highly lipid-soluble, would be cleared more slowly from peripheral tissues after the infusion is stopped. Any residual propofol, even at subhypnotic concentrations, might thus be able to reduce post-surgical pain. In this chapter, we discuss new research results concerning propofol and its effect on nociception, as well as the potential beneficial effect of propofol on post-operative pain.

Original languageEnglish (US)
Title of host publicationPropofol: Pharmacokinetics, Medical Uses and Potential Health Effects
PublisherNova Science Publishers, Inc.
Pages1-14
Number of pages14
ISBN (Print)9781631174377, 9781631174360
StatePublished - Jan 1 2014

Fingerprint

Nociception
Propofol
Pain
Central Nervous System Depressants
Transient Receptor Potential Channels
Intradermal Injections
Pain Perception
Postoperative Pain
Intravenous Injections
Analgesia
General Anesthesia
Analgesics
Anesthesia
Pharmacokinetics
Lipids

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Carstens, E., Antognini, J. F., & Takechi, K. (2014). Propofol and nociception. In Propofol: Pharmacokinetics, Medical Uses and Potential Health Effects (pp. 1-14). Nova Science Publishers, Inc..

Propofol and nociception. / Carstens, Earl; Antognini, Joseph F.; Takechi, Kenichi.

Propofol: Pharmacokinetics, Medical Uses and Potential Health Effects. Nova Science Publishers, Inc., 2014. p. 1-14.

Research output: Chapter in Book/Report/Conference proceedingChapter

Carstens, E, Antognini, JF & Takechi, K 2014, Propofol and nociception. in Propofol: Pharmacokinetics, Medical Uses and Potential Health Effects. Nova Science Publishers, Inc., pp. 1-14.
Carstens E, Antognini JF, Takechi K. Propofol and nociception. In Propofol: Pharmacokinetics, Medical Uses and Potential Health Effects. Nova Science Publishers, Inc. 2014. p. 1-14
Carstens, Earl ; Antognini, Joseph F. ; Takechi, Kenichi. / Propofol and nociception. Propofol: Pharmacokinetics, Medical Uses and Potential Health Effects. Nova Science Publishers, Inc., 2014. pp. 1-14
@inbook{4974322db88149b492fe42c153e580c1,
title = "Propofol and nociception",
abstract = "Propofol (2,6-diisopropylphenol) is an injectable agent that is commonly used for general anesthesia. In addition to its central nervous system depressant action, propofol may exhibit temporary analgesia although this has been debated. Several studies have reported analgesic effects of subhypnotic doses of propofol on pain perception in humans. Moreover, some recent clinical studies have reported that surgery patients receiving propofol anesthesia experienced reduced postoperative pain. These findings are in marked contrast to the well-known algesic effects of propofol, which induces pain upon intravenous injection or intradermal injection in humans and elicits nocifensive behavior in mice. Recent experiments also demonstrate that propofol directly activates the thermosensitive transient receptor potential (TRP) channels TRPV1 and TRPA1 , which are well-known receptors involved in nociception. Based on 3-compartment models of drug pharmacokinetics, it would be expected that propofol, which is highly lipid-soluble, would be cleared more slowly from peripheral tissues after the infusion is stopped. Any residual propofol, even at subhypnotic concentrations, might thus be able to reduce post-surgical pain. In this chapter, we discuss new research results concerning propofol and its effect on nociception, as well as the potential beneficial effect of propofol on post-operative pain.",
author = "Earl Carstens and Antognini, {Joseph F.} and Kenichi Takechi",
year = "2014",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781631174377",
pages = "1--14",
booktitle = "Propofol: Pharmacokinetics, Medical Uses and Potential Health Effects",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Propofol and nociception

AU - Carstens, Earl

AU - Antognini, Joseph F.

AU - Takechi, Kenichi

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Propofol (2,6-diisopropylphenol) is an injectable agent that is commonly used for general anesthesia. In addition to its central nervous system depressant action, propofol may exhibit temporary analgesia although this has been debated. Several studies have reported analgesic effects of subhypnotic doses of propofol on pain perception in humans. Moreover, some recent clinical studies have reported that surgery patients receiving propofol anesthesia experienced reduced postoperative pain. These findings are in marked contrast to the well-known algesic effects of propofol, which induces pain upon intravenous injection or intradermal injection in humans and elicits nocifensive behavior in mice. Recent experiments also demonstrate that propofol directly activates the thermosensitive transient receptor potential (TRP) channels TRPV1 and TRPA1 , which are well-known receptors involved in nociception. Based on 3-compartment models of drug pharmacokinetics, it would be expected that propofol, which is highly lipid-soluble, would be cleared more slowly from peripheral tissues after the infusion is stopped. Any residual propofol, even at subhypnotic concentrations, might thus be able to reduce post-surgical pain. In this chapter, we discuss new research results concerning propofol and its effect on nociception, as well as the potential beneficial effect of propofol on post-operative pain.

AB - Propofol (2,6-diisopropylphenol) is an injectable agent that is commonly used for general anesthesia. In addition to its central nervous system depressant action, propofol may exhibit temporary analgesia although this has been debated. Several studies have reported analgesic effects of subhypnotic doses of propofol on pain perception in humans. Moreover, some recent clinical studies have reported that surgery patients receiving propofol anesthesia experienced reduced postoperative pain. These findings are in marked contrast to the well-known algesic effects of propofol, which induces pain upon intravenous injection or intradermal injection in humans and elicits nocifensive behavior in mice. Recent experiments also demonstrate that propofol directly activates the thermosensitive transient receptor potential (TRP) channels TRPV1 and TRPA1 , which are well-known receptors involved in nociception. Based on 3-compartment models of drug pharmacokinetics, it would be expected that propofol, which is highly lipid-soluble, would be cleared more slowly from peripheral tissues after the infusion is stopped. Any residual propofol, even at subhypnotic concentrations, might thus be able to reduce post-surgical pain. In this chapter, we discuss new research results concerning propofol and its effect on nociception, as well as the potential beneficial effect of propofol on post-operative pain.

UR - http://www.scopus.com/inward/record.url?scp=84949232474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949232474&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84949232474

SN - 9781631174377

SN - 9781631174360

SP - 1

EP - 14

BT - Propofol: Pharmacokinetics, Medical Uses and Potential Health Effects

PB - Nova Science Publishers, Inc.

ER -